1. Home
  2. AJG vs GSK Comparison

AJG vs GSK Comparison

Compare AJG & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AJG
  • GSK
  • Stock Information
  • Founded
  • AJG 1927
  • GSK 1715
  • Country
  • AJG United States
  • GSK United Kingdom
  • Employees
  • AJG N/A
  • GSK N/A
  • Industry
  • AJG Specialty Insurers
  • GSK Biotechnology: Pharmaceutical Preparations
  • Sector
  • AJG Finance
  • GSK Health Care
  • Exchange
  • AJG Nasdaq
  • GSK Nasdaq
  • Market Cap
  • AJG 73.5B
  • GSK 71.7B
  • IPO Year
  • AJG N/A
  • GSK N/A
  • Fundamental
  • Price
  • AJG $322.35
  • GSK $37.42
  • Analyst Decision
  • AJG Hold
  • GSK Hold
  • Analyst Count
  • AJG 14
  • GSK 4
  • Target Price
  • AJG $306.93
  • GSK $47.00
  • AVG Volume (30 Days)
  • AJG 1.5M
  • GSK 6.2M
  • Earning Date
  • AJG 05-01-2025
  • GSK 04-30-2025
  • Dividend Yield
  • AJG 0.81%
  • GSK 4.15%
  • EPS Growth
  • AJG 47.06
  • GSK N/A
  • EPS
  • AJG 6.50
  • GSK 0.78
  • Revenue
  • AJG $10,927,400,000.00
  • GSK $39,280,393,592.00
  • Revenue This Year
  • AJG $32.05
  • GSK $7.60
  • Revenue Next Year
  • AJG $19.25
  • GSK $5.24
  • P/E Ratio
  • AJG $49.58
  • GSK $23.31
  • Revenue Growth
  • AJG 14.31
  • GSK 3.46
  • 52 Week Low
  • AJG $232.27
  • GSK $31.72
  • 52 Week High
  • AJG $350.70
  • GSK $45.93
  • Technical
  • Relative Strength Index (RSI)
  • AJG 44.82
  • GSK 54.43
  • Support Level
  • AJG $315.71
  • GSK $35.08
  • Resistance Level
  • AJG $336.69
  • GSK $36.16
  • Average True Range (ATR)
  • AJG 11.90
  • GSK 1.05
  • MACD
  • AJG -0.72
  • GSK 0.28
  • Stochastic Oscillator
  • AJG 47.60
  • GSK 97.58

About AJG Arthur J. Gallagher & Co.

Arthur J. Gallagher & Co provides insurance brokerage and consulting services to middle-market entities around the world. The majority of the company's revenue comes from its brokerage segment, where it negotiates and places its customers with insurance companies that provide, among other types, property/casualty and health insurance. The company's primary source of revenue in the brokerage segment is commissioning from the insurance companies. The company also generates significant revenue in its corporate segment, which includes clean energy investment and other investment income. The company generates most of its revenue in the United States, with the remaining revenue coming primarily from Australia, Bermuda, Canada, the Caribbean, New Zealand, and the United Kingdom.

About GSK GSK plc (Each representing two)

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Share on Social Networks: